Cargando…
Effectiveness and safety of four different beta‐blockers in patients with chronic heart failure
In this study, we evaluated the effectiveness and safety of bisoprolol, metoprolol, carvedilol, and nebivolol in the treatment of chronic heart failure. The results demonstrated that bisoprolol improved the prognosis of chronic heart failure in comparison with carvedilol, and carvedilol exerted simi...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823244/ https://www.ncbi.nlm.nih.gov/pubmed/36628295 http://dx.doi.org/10.1002/mco2.199 |
| _version_ | 1784866112760971264 |
|---|---|
| author | Liu, Baoshan Zhang, Rui Zhang, Aiyuan Wang, Guodong Xu, Jiupan Zhang, Yun Liu, Yanping Hao, Panpan |
| author_facet | Liu, Baoshan Zhang, Rui Zhang, Aiyuan Wang, Guodong Xu, Jiupan Zhang, Yun Liu, Yanping Hao, Panpan |
| author_sort | Liu, Baoshan |
| collection | PubMed |
| description | In this study, we evaluated the effectiveness and safety of bisoprolol, metoprolol, carvedilol, and nebivolol in the treatment of chronic heart failure. The results demonstrated that bisoprolol improved the prognosis of chronic heart failure in comparison with carvedilol, and carvedilol exerted similar effects as metoprolol succinate and nebivolol and better effect than metoprolol tartrate (evidence levels: bisoprolol > carvedilol = metoprolol succinate = nebivolol > metoprolol tartrate; “ > ” means “prior to”). [Image: see text] |
| format | Online Article Text |
| id | pubmed-9823244 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98232442023-01-09 Effectiveness and safety of four different beta‐blockers in patients with chronic heart failure Liu, Baoshan Zhang, Rui Zhang, Aiyuan Wang, Guodong Xu, Jiupan Zhang, Yun Liu, Yanping Hao, Panpan MedComm (2020) Letter to the Editor In this study, we evaluated the effectiveness and safety of bisoprolol, metoprolol, carvedilol, and nebivolol in the treatment of chronic heart failure. The results demonstrated that bisoprolol improved the prognosis of chronic heart failure in comparison with carvedilol, and carvedilol exerted similar effects as metoprolol succinate and nebivolol and better effect than metoprolol tartrate (evidence levels: bisoprolol > carvedilol = metoprolol succinate = nebivolol > metoprolol tartrate; “ > ” means “prior to”). [Image: see text] John Wiley and Sons Inc. 2023-01-06 /pmc/articles/PMC9823244/ /pubmed/36628295 http://dx.doi.org/10.1002/mco2.199 Text en © 2023 The Authors. MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Liu, Baoshan Zhang, Rui Zhang, Aiyuan Wang, Guodong Xu, Jiupan Zhang, Yun Liu, Yanping Hao, Panpan Effectiveness and safety of four different beta‐blockers in patients with chronic heart failure |
| title | Effectiveness and safety of four different beta‐blockers in patients with chronic heart failure |
| title_full | Effectiveness and safety of four different beta‐blockers in patients with chronic heart failure |
| title_fullStr | Effectiveness and safety of four different beta‐blockers in patients with chronic heart failure |
| title_full_unstemmed | Effectiveness and safety of four different beta‐blockers in patients with chronic heart failure |
| title_short | Effectiveness and safety of four different beta‐blockers in patients with chronic heart failure |
| title_sort | effectiveness and safety of four different beta‐blockers in patients with chronic heart failure |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823244/ https://www.ncbi.nlm.nih.gov/pubmed/36628295 http://dx.doi.org/10.1002/mco2.199 |
| work_keys_str_mv | AT liubaoshan effectivenessandsafetyoffourdifferentbetablockersinpatientswithchronicheartfailure AT zhangrui effectivenessandsafetyoffourdifferentbetablockersinpatientswithchronicheartfailure AT zhangaiyuan effectivenessandsafetyoffourdifferentbetablockersinpatientswithchronicheartfailure AT wangguodong effectivenessandsafetyoffourdifferentbetablockersinpatientswithchronicheartfailure AT xujiupan effectivenessandsafetyoffourdifferentbetablockersinpatientswithchronicheartfailure AT zhangyun effectivenessandsafetyoffourdifferentbetablockersinpatientswithchronicheartfailure AT liuyanping effectivenessandsafetyoffourdifferentbetablockersinpatientswithchronicheartfailure AT haopanpan effectivenessandsafetyoffourdifferentbetablockersinpatientswithchronicheartfailure |